| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/18/2007 | WO2007006561A2 Improved crystalline form of the compound a-348441 |
| 01/18/2007 | WO2007006546A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006211A1 Dipeptidyl peptidase iv (ddp iv) inhibitors, preparation methods and uses thereof |
| 01/18/2007 | WO2007006152A1 Compositions from buckwheat for management of diabetes |
| 01/18/2007 | WO2006124713A3 4-biarylyl-1-phenylazetidin-2-ones |
| 01/18/2007 | WO2006114775A3 Treatment of insulin resistance syndrome |
| 01/18/2007 | WO2006108008A3 A method and composition for nutritionally improving glucose control and insulin action |
| 01/18/2007 | WO2006107902A9 Use of spirostenols to treat mitochondrial disorders |
| 01/18/2007 | WO2006088748A3 Method for treating obesity |
| 01/18/2007 | WO2006076231A3 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 01/18/2007 | WO2006061140A3 Composition of ssao substrates and metal compounds of the vla and vlb groups of the periodic table |
| 01/18/2007 | WO2006055526A3 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 01/18/2007 | WO2006014381A3 Use of thioflavin radiolabeled derivatives in amyloid imaging gor assessing anti-amyloid therapies |
| 01/18/2007 | US20070015797 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015745 e.g. 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; antidiabetic agent, obesity |
| 01/18/2007 | US20070015737 Compounds for inhibiting diseases and preparing cells for transplantation |
| 01/18/2007 | US20070015732 Adenosine receptor antagonists and methods of making and using the same |
| 01/18/2007 | US20070015687 Synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 01/18/2007 | US20070015269 Crystals of DPP-IV |
| 01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
| 01/18/2007 | US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
| 01/18/2007 | US20070014742 A mixture of polypeptides, as calcium binding protein for reducing bone loss and reducing renal phosphate excretion; biodrug for treating bone disorders; injectable solution or dispersed in toothpaste or a mouthwash; drug delivery gum patch |
| 01/18/2007 | DE102005033099A1 Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung New 1,4-benzothiazepine-1,1-Dioxidderivat with improved properties, process for its preparation, pharmaceuticals comprising this compound and its use |
| 01/18/2007 | CA2615118A1 Pharmaceutical composition containing ppar.gamma. agonist |
| 01/18/2007 | CA2615055A1 Ppar [alpha/gamma] agonists and processes of preparing |
| 01/18/2007 | CA2614834A1 Combination of a dpp-iv inhibitor and a cannabinoid cb1 receptor antagonist |
| 01/18/2007 | CA2614796A1 Cynara scolymus extracts, the use thereof and formulations containing them |
| 01/18/2007 | CA2614688A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| 01/18/2007 | CA2614545A1 Choline salt crystal of azulene compound |
| 01/18/2007 | CA2614544A1 Heterocycle-substituted benzimidazole derivative |
| 01/18/2007 | CA2614518A1 Dicycloalkyl urea glucokinase activators |
| 01/18/2007 | CA2614048A1 Improved crystalline form of the compound a-348441 |
| 01/18/2007 | CA2613141A1 Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders |
| 01/17/2007 | EP1743945A1 Screening method |
| 01/17/2007 | EP1743903A2 Methods and compositions for treating disorders involving excitotoxicity |
| 01/17/2007 | EP1743892A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/17/2007 | EP1743891A1 Heterocyclic compounds and methods for modulating CXCR3 function |
| 01/17/2007 | EP1743890A1 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments |
| 01/17/2007 | EP1743888A1 Carbonyl substituted pyrazoline compounds, their preparation and use as CB1 receptor modulators |
| 01/17/2007 | EP1743887A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as CB1 modulators |
| 01/17/2007 | EP1743884A1 Progrugs to d-prolines |
| 01/17/2007 | EP1743676A1 Heterocyclic boronic acid derivatives, dipeptidyl peptidase IV inhibitors |
| 01/17/2007 | EP1743655A1 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/17/2007 | EP1743641A1 Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
| 01/17/2007 | EP1743640A1 Use of substituted pyrazoline compounds for the preparation of paediatric medicaments |
| 01/17/2007 | EP1743638A1 Pharmaceutical formulations of substituted pyrazoline compounds |
| 01/17/2007 | EP1743637A1 Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome |
| 01/17/2007 | EP1743636A1 Combination of a substituted pyrazoline compound and a drug used in food-related disorders |
| 01/17/2007 | EP1743634A1 Alcohol metabolism accelerating composition, and food or drink containing the composition |
| 01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
| 01/17/2007 | EP1743630A2 Pharmaceutical combination |
| 01/17/2007 | EP1743531A1 Aggregates of eyeballs of crustaceans, usage, foods coataining the same, and production processes |
| 01/17/2007 | EP1743524A1 An animal model for type II diabetes mellitus and syndrome x |
| 01/17/2007 | EP1743522A1 An animal model for type II diabetes mellitus and syndrome x |
| 01/17/2007 | EP1742949A1 Novel-2-(piperazin-1-yl)-and-2-([1,4]diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, production and use thereof as medicament for the treatment of diabetes mellitus |
| 01/17/2007 | EP1742939A2 Novel alkyne compounds exhibiting an mch antagonistic effect and drugs containing said compounds |
| 01/17/2007 | EP1742923A1 Pyrazole phenyl derivatives as ppar activators |
| 01/17/2007 | EP1742663A2 Compositions capable of facilitating penetration across a biological barrier |
| 01/17/2007 | EP1742655A2 Use of ghrelin for the treatment of hyperthyroidism |
| 01/17/2007 | EP1742647A1 Trace elements |
| 01/17/2007 | EP1450852B1 Ptp10d nucleic acids and peptides involved in the regulation of energy homeostasis |
| 01/17/2007 | EP1400518B1 Heterocyclic compound derivatives and medicines |
| 01/17/2007 | EP1392309B1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/17/2007 | EP1345501B1 Nutritional and therapeutical preparations having antioxidant activity |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1180518B1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 01/17/2007 | EP1065945B1 Method for producing a fat mixture |
| 01/17/2007 | EP0954588B1 Ob fusion protein compositions and methods |
| 01/17/2007 | CN1898260A Peptides with anti-obesity activity and other related uses |
| 01/17/2007 | CN1898209A Pyridine carboxylic acid derivatives as glucokinase modulators |
| 01/17/2007 | CN1898203A Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 01/17/2007 | CN1898202A Anti-hypercholesterolemic compounds |
| 01/17/2007 | CN1897974A Medicinal lipolysis of accumulations of fat |
| 01/17/2007 | CN1897955A Glycerophospholipids containing omega-3 and omega-6 fatty acids |
| 01/17/2007 | CN1897944A Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 01/17/2007 | CN1897939A Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
| 01/17/2007 | CN1897828A Health food, process for producing the same and dried matter or extract |
| 01/17/2007 | CN1897824A Functional component-enriched barley malt rootlets and process for producing the same |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896097A Peptide for promoting insulin release of frog and its use in production of drugs |
| 01/17/2007 | CN1896088A C－芳基葡糖苷sglt2抑制剂 C- aryl glucoside sglt2 inhibitors |
| 01/17/2007 | CN1896078A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
| 01/17/2007 | CN1896069A Substituted-thiazole-4-ketone, its preparation and use |
| 01/17/2007 | CN1896062A New phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/17/2007 | CN1896045A Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/17/2007 | CN1895656A Weight-loss beverage |
| 01/17/2007 | CN1895646A Chinese medicine for treating diabetes mellitus and its preparation |
| 01/17/2007 | CN1895621A Medicine for treating cerebrovascular accident induced by high blood fat |
| 01/17/2007 | CN1895607A Extraction and its use for garlicin and garlic active component composition |
| 01/17/2007 | CN1895596A Chinese medicine for treating diabetes and its preparation |
| 01/17/2007 | CN1895589A Incretin beverage |
| 01/17/2007 | CN1895579A Natural insulin revivification phenethy biguanide and its preparation |
| 01/17/2007 | CN1895557A Chinese-medicinal herb for treating hypertension, high-blood-fat and hyperglycosemia |
| 01/17/2007 | CN1895548A Diabetes treatment for tonifying Qi and nourishing Yang by ginseng, fragrant solomonseal rhizome and barbary wolfbery fruit |
| 01/17/2007 | CN1895547A Medicine for treating diabetes and its preparation |
| 01/17/2007 | CN1895546A Lycium chinensis polyose medicinal composition with therapeutic and health-care functions |